A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

PHASE2CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Lymphoma
Interventions
DRUG

Parsaclisib

Parsaclisib tablets administered orally with water and without regard to food.

Trial Locations (103)

9000

Universitair Ziekenhuis Gent, Ghent

10034

Fakultni Nemocnice Kralovske Vinohadry, Interni Hematologicka Klinika, Prague

10126

Azienda Ospedaliero Universitaria Citta Della Salute E Della Scienza, Torino

11042

Clinical Research Alliance, Inc., New Hyde Park

17325

Gettysburg Cancer Center, Gettysburg

20133

Fondazione Irccs Istituto Nazionale Dei Tumori, Milan

20162

Grande Ospedale Metropolitano Niguarda, Milan

22162

Ospedale Niguarda Ca Granda, Milan

27705

Duke University Medical Center, Durham

28007

Hospital General Universitario Gregorio Maranon, Madrid

28033

Md Anderson Cancer Centre Madrid, Madrid

28034

Hospital Universitario Ramon Y Cajal, Madrid

28040

Fundacion Jimenez Diaz University Hospital, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario de La Paz, Madrid

28100

Aou Maggiore Della Carita, Novara

30008

Hospital General Universitario Morales Meseguer, Murcia

31008

Complejo Hospitalario de Navarra, Pamplona

31096

Rambam Medical Center, Haifa

33647

Moffitt Cancer Center, Tampa

33880

Bond & Steele Clinic, P.A., Winter Haven

34613

Asclepes Research Centers, Brooksville

35205

University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham

35392

Justus-Liebig University, Giessen

37007

Hospital Clinico Universitario de Salamanca, Salamanca

37044

Chru Hopitaux de Tours, Hospital Bretonneau, Tours

38043

University Hospital Grenoble, Grenoble

38700

Centre Hospitalier Universitaire de Grenoble, La Tronche

39401

Hattiesburg Clinic Hematology, Hattiesburg

40138

Centro Ricerche Cliniche, Bologna

41005

Hospital Universitario Virgen del Rocio, Seville

41063

Kliniken Maria Hilf, Mönchengladbach

41124

A.O.U. Di Modena - Policlinico, Modena

45122

Universitaetsklinikum Essen, Essen

45147

Universit�Tsklinikum Essen, Essen

45230

Oncology Hematology Care, Inc., Cincinnati

46015

Hospital Arnau de Vilanova, Valencia

46017

Hospital Universitario Dr. Peset, Valencia

46026

Hospital Universitario Y Politecnic La Fe, Valencia

53100

Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria Alle Scotte, Siena

55131

Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz

60153

Loyola University Medical Center, Maywood

60612

Rush University Medical Center, Chicago

60714

Illinois Cancer Specialists, Niles

63230

Chu de Clermont - Ferrand- Hospital Estaing, Clermont-Ferrand

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

69008

Hospices Civils de Lyon Centre Hospitalier Lyon Sud, Lyon

69310

Centre Hospitalier Lyon-Sud, Pierre-Bénite

75010

Hopital Saint-Louis, Paris

75013

H�Pital Universitaire Piti�-Salp�Tri�Re, Paris

75702

Texas Oncology - Tyler, Tyler

76038

Centre Henri Becquerel, Rouen

77380

Renovatio Clinical, The Woodlands

78157

Centre Hospitalier de Versailles, Le Chesnay

78240

Texas Oncology San Antonio, San Antonio

78705

Texas Oncology, Austin

80012

Rocky Mountain Cancer Center-Aurora, Aurora

80131

A.O.U. Federico Ii, Napoli

80634

Rotkreuzklinikum Munich, München

85925

Centre Hospitalier Departemental - La-Roche-Sur-Yon - Les Oudairies, La Roche-sur-Yon

86021

Centre Hospitalier Universitaire de Poitiers, Poitiers

86150

Praxis Brudler, Heinrich, Bangerter, Augsburg

89081

Universit�Tsklinikum Ulm, Ulm

90000

Hadassah Hebrew University Medical Center, Jerusalem

90146

Ospedali Riuniti Villa Sofia Cervello, Palermo

91120

Hadassah Hebrew University Medical Center Ein Karem Hadassah, Jerusalem

93000

Avicenne Hospital, Bobigny

94010

Centre Hospitalier Universitaire Henri Mondor, Créteil

94805

Institute Gustave Roussy (Igr), Villejuif

95123

Azienda Policlinico Vittorio Emanuele, Catania

95403

St. Joseph Heritage Healthcare, Santa Rosa

97227

Kaiser Permanente - Northwest, Portland

97401

Willamette Valley Cancer Institute, Eugene

98902

Yakima Valley Memorial Hospital/North Star, Yakima

4841492

Rabin Medical Center - Beilinson Hospital, Petah Tikva

Unknown

Institut Jules Bordet, Brussels

07100

Hopital de Jolimont, La Louvière

03000

Universitaire Ziekenhuis Leuven - Gasthuisberg, Leuven

500 05

Fakultni Nemocnice Hradec Kralove, Hradec Králové

Fakultni Nemocnice Kralovske Vinohrady, Prague

128 08

Charles University General Hospital, Prague

09000

Aalborg University Hospital, Aalborg

DK-8000

Aarhus Universitets Hospital, Aarhus

05000

Odense Universitetshospital (Ouh) (Odense University Hospital), Odense C

04000

Zealand University Hospital, Roskilde

06189

Centre Antoine Lacassagne, Nice

00161

Sapienza University, Rome

43-300

Beskidzkie Centrum Onkologii Im.Jana Pawla Ii, Bielsko-Biala

36-200

Szpital Specjalistyczny W Brzozowie, Podkarpacki Osrodek Onkologiczny Im.Ks.B.Markiewicza, Brzozów

80-952

University Clinical Center, Gdansk

30-510

Pratia McM Krakow, Krakow

97-200

Nu-Med Centrum Diagnostykii I Terapii Onkologicznej, Tomaszów Mazowiecki

02-781

Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw

08003

Hospital Del Mar, Barcelona

08035

Hospital General Universitari Vall D Hebron, Barcelona

08221

Hospital Universitari Mutua Terrassa, Barcelona

08916

Institut Catala D Oncologia, Barcelona

09006

Hospital Universitario de Burgos, Burgos

B9 5SS

Birmingham Heartlands Hospital, Birmingham

EH4 2XU

Western General Hospital, Edinburgh

NW1 2PG

University College London Hospitals (Uclh), London

PL6 8DH

Derriford Hospital, Plymouth

S10 2JF

Royal Hallamshire Hospital, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY

NCT03235544 - A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor | Biotech Hunter | Biotech Hunter